| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.006 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |